Enoxaparin sodium
- Generic Name
- Enoxaparin sodium
- Brand Names
- Lovenox, Inhixa
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9005-49-6
- Unique Ingredient Identifier
- E47C0NF7LV
- Background
Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies. Enoxaparin markedly reduces the incidence of venous thromboembolism in hosp...
- Indication
Enoxaparin is indicated for the prevention of ischemic complications in unstable angina and in non Q-wave myocardial infarction; it is indicated in conjunction with percutaneous intervention and/or other treatment for the management of acute ST elevation myocardial infarction.
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Acute Myocardial Infarction With ST Segment Elevation, Deep Vein Thrombosis, Ischemic complications caused by non-q wave myocardial infarction, Ischemic complications caused by unstable angina
- Associated Therapies
- Percutaneous Coronary Intervention (PCI)
Timing of Initiation of LMWH Administration in Pregnant Women With APS
- Conditions
- Interventions
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- Mohamed Sayed Abdelhafez
- Target Recruit Count
- 100
- Registration Number
- NCT02326051
- Locations
- 🇪🇬
Obstetrics and Gynecology Department in Mansoura University Hospital, Mansourah, Dakahlia, Egypt
🇪🇬Private practice settings, Mansourah, Dakahlia, Egypt
Use of Warfarin After the First Trimester in Pregnant Women With APS
- Conditions
- Interventions
- First Posted Date
- 2014-11-27
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Mohamed Sayed Abdelhafez
- Target Recruit Count
- 100
- Registration Number
- NCT02303171
- Locations
- 🇪🇬
Obstetrics and Gynecology Department in Mansoura University Hospital, Mansourah, Dakahlia, Egypt
🇪🇬Private practice settings, Mansourah, Dakahlia, Egypt
OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study
- Conditions
- Interventions
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- McMaster University
- Target Recruit Count
- 300
- Registration Number
- NCT02260908
- Locations
- 🇨🇦
Hamilton Health Sciences- General site, Hamilton, Ontario, Canada
Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.
- Conditions
- Interventions
- First Posted Date
- 2014-09-05
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Chemi S.p.A.
- Target Recruit Count
- 47
- Registration Number
- NCT02232802
- Locations
- 🇬🇧
Simbec Research Ltd, Merthyr Tydfil, United Kingdom
PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2020-05-21
- Target Recruit Count
- 40
- Registration Number
- NCT02206100
- Locations
- 🇺🇸
Quintiles, Overland Park, Kansas, United States
Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)
- Conditions
- Interventions
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 5989
- Registration Number
- NCT02181985
A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting
- Conditions
- Interventions
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1606
- Registration Number
- NCT02181998
Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke
- First Posted Date
- 2014-06-09
- Last Posted Date
- 2014-06-09
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT02159287
- Locations
- 🇮🇷
Faghihi hospital, Shiraz, Fars, Iran, Islamic Republic of
🇮🇷Nemazi hospital, Shiraz, Fars, Iran, Islamic Republic of
Enoxamed Study in the Treatment of Acute Coronary Syndromes
- First Posted Date
- 2014-06-02
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 50
- Registration Number
- NCT02152423
- Locations
- 🇹🇳
Emergency Department of University Hospital of Monastir, Monastir, Tunisia
Pharmacokinetics of Enoxaparin in Intensive Care Patients
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Tampere University Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT02095509
- Locations
- 🇫🇮
Tampere University Hospital, Tampere, Pirkanmaa, Finland
🇫🇮Helsinki University Central Hospital, Meilahti, Helsinki, Uusimaa, Finland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.